Search and Browse
Download
Enter Data
BDBM37655 (4E)-5-(3-bromophenyl)-1-(5-methyl-1,2-oxazol-3-yl)-4-[(4-methylphenyl)-oxidanyl-methylidene]pyrrolidine-2,3-dione::(4E)-5-(3-bromophenyl)-4-[hydroxy(p-tolyl)methylene]-1-(5-methylisoxazol-3-yl)pyrrolidine-2,3-quinone::(4E)-5-(3-bromophenyl)-4-[hydroxy-(4-methylphenyl)methylidene]-1-(5-methyl-1,2-oxazol-3-yl)pyrrolidine-2,3-dione::(4E)-5-(3-bromophenyl)-4-[hydroxy-(4-methylphenyl)methylidene]-1-(5-methyl-3-isoxazolyl)pyrrolidine-2,3-dione::MLS000041516::SMR000058018::cid_5389438
SMILES: Cc1cc(no1)N1C(C(C(=O)c2ccc(C)cc2)C(=O)C1=O)c1cccc(Br)c1
InChI Key: InChIKey=AJCSMKLQIMMORL-UHFFFAOYSA-N
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| fMet-Leu-Phe receptor (Human) | BDBM37655![]() (SMR000058018 | (4E)-5-(3-bromophenyl)-4-[hydroxy-(...) | GoogleScholar | UniChem | n/a | n/a | >6.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| N-formyl peptide receptor 2 (Human) | BDBM37655![]() (SMR000058018 | (4E)-5-(3-bromophenyl)-4-[hydroxy-(...) | GoogleScholar | UniChem | n/a | n/a | >6.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| N-formyl peptide receptor 2 (Human) | BDBM37655![]() (SMR000058018 | (4E)-5-(3-bromophenyl)-4-[hydroxy-(...) | GoogleScholar | UniChem | >4.03E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| fMet-Leu-Phe receptor (Human) | BDBM37655![]() (SMR000058018 | (4E)-5-(3-bromophenyl)-4-[hydroxy-(...) | GoogleScholar | UniChem | >4.37E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
| More data for this Ligand-Target Pair | |||||||||||||